USSTOCK.TODAY
Market Closed
Log in Sign up

Oyster Therapeutics Completes $60 million Series A-2 Funding

Pharmaceutical Business Review · ·by G4L

LLY Lilly(Eli) & Co
$1415.55 -1.13%
View chart & analysis →
  1. 1Oyster Therapeutics has secured $60 million in Series A-2 funding.
  2. 24BIO Capital led the investment.
  3. 3Oyster Therapeutics has entered into a sponsored research partnership with Massachusetts General Hospital.

So what's the key point?

Oyster Therapeutics received $60 million in investment. 4BIO Capital led the round, and the company will conduct research in partnership with a hospital.

Source Pharmaceutical Business Review · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →